4//SEC Filing
Shiferman Gregory L. 4
Accession 0001562180-25-002756
CIK 0001597553other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:36 PM ET
Size
7.1 KB
Accession
0001562180-25-002756
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Tax Payment
Common Stock
2025-03-24$8.21/sh−79$649→ 30,680 total
Footnotes (1)
- [F1]On March 24, 2025, the reporting person vested 235 shares of time-based restricted stock units (RSUs) granted on October 28, 2021 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 25% on September 24, 2022, and vests quarterly thereafter in twelve equal installments. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0002041689
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 4:36 PM ET
- Size
- 7.1 KB